share_log

With 51% Ownership, Insiders at China Medical System Holdings Limited (HKG:867) Are Pretty Optimistic and Have Been Buying Recently

With 51% Ownership, Insiders at China Medical System Holdings Limited (HKG:867) Are Pretty Optimistic and Have Been Buying Recently

在中国医疗系统控股有限公司(HKG:867),持股比例达51%的内部人士非常乐观,并最近一直在购买。
Simply Wall St ·  06/21 02:57

Key Insights

主要见解

  • Insiders appear to have a vested interest in China Medical System Holdings' growth, as seen by their sizeable ownership
  • A total of 2 investors have a majority stake in the company with 50% ownership
  • Recent purchases by insiders
  • 从中看出,内部人士对于中国医药系统控股有着很大的持股兴趣。
  • 共有2位投资者拥有该公司50%的所有权。
  • 最近有内部人员购买。

Every investor in China Medical System Holdings Limited (HKG:867) should be aware of the most powerful shareholder groups. With 51% stake, individual insiders possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

作为中国医药系统控股的投资者,您应该注意到最大的股东集团。由于个人内部人士持有51%的股份,所以拥有公司的最大股份。换句话说,该集团面临的最大上行潜力(或下行风险)是很大的。

Notably, insiders have bought shares recently. This could signal that stock prices could go up and insiders are here for it.

内部人士最近购买了股票,这可能意味着股价可能会上涨而内部人士也可以从中受益。

Let's delve deeper into each type of owner of China Medical System Holdings, beginning with the chart below.

让我们深入了解每种拥有者类型的中国医药系统控股,从下面的图表开始。

ownership-breakdown
SEHK:867 Ownership Breakdown June 21st 2024
SEHK:867股权分布2024年6月21日

What Does The Institutional Ownership Tell Us About China Medical System Holdings?

关于中国医药系统控股的机构投资者持股,我们还可以看出,机构投资者在该公司持有相当数量的股份。这意味着为这些机构投资的分析师已经研究了该股并且看好它。但就像其他任何人一样,他们也可能犯错误。当多个机构拥有一支股票时,总会存在他们涌入'众筹式交易'的风险。这种风险在一个没有增长历史的公司中更高。您可以在下面看到中国医药系统控股的历史收益和营业收入,但请记住,故事总是有更多的内容。

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。

As you can see, institutional investors have a fair amount of stake in China Medical System Holdings. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see China Medical System Holdings' historic earnings and revenue below, but keep in mind there's always more to the story.

我们尤其需要考虑持有公司的不同群体,但更重要的是考虑其他因素。例如,我们已经发现了中国医药系统控股2个警示信号,您应该注意到这些信号。

earnings-and-revenue-growth
SEHK:867 Earnings and Revenue Growth June 21st 2024
SEHK:867收入和营业收入增长2024年6月21日

China Medical System Holdings is not owned by hedge funds. The company's CEO Kong Lam is the largest shareholder with 47% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 2.9% and 2.1%, of the shares outstanding, respectively. Interestingly, the second-largest shareholder, Hongbing Chen is also Chief Operating Officer, again, pointing towards strong insider ownership amongst the company's top shareholders.

中国医药系统控股不是对冲基金持有的公司。公司CEO孔蓝拥有47%的流通股份,同时,第二大和第三大股东分别拥有流通股份的2.9%和2.1%。有趣的是,第二大股东陈红冰也是首席运营官,再次表明公司内部人士在公司的最大股东中占有很高的比例。

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

为了使我们的研究更有趣,我们发现前2名股东拥有该公司的大部分所有权,这意味着他们足够强大,可以影响公司的决策。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

虽然仔细研究公司的机构持股数据是有意义的,但研究分析师对该股票的看法也是有意义的。有相当数量的分析师在跟踪该股票,因此了解他们对于未来发展的总体看法可能会有所帮助。

Insider Ownership Of China Medical System Holdings

中国医药系统控股的内部人士拥有公司的大部分股份。这意味着他们可以共同为公司做出决策。这意味着内部人员持有逾86亿港元的股份,并与股东的利益高度一致。您可以在此处查看他们是否一直减持股份。

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司内部人员的定义可能是主观的,并且在不同的司法管辖区之间是不同的。我们的数据反映了个别内部人员,至少捕捉到了董事会成员。公司管理业务,但首席执行官即使是董事会成员也必须向董事会负责。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

当内部人持股情况表明领导层思考和公司真正所有者一样时,内部所有权是积极的。然而,高达内部人士所有权也可能为公司内的小团体带来巨大的权力。在某些情况下,这可能是负面的。

Our most recent data indicates that insiders own the majority of China Medical System Holdings Limited. This means they can collectively make decisions for the company. That means insiders have a very meaningful HK$8.6b stake in this HK$17b business. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if they have been selling down their stake.

普通公众(包括散户投资者)拥有该公司29%的股份,因此他们不容易被忽视。虽然这个拥股比例相当大,但如果决定不与其他大股东保持同步,则可能无法改变公司政策。

General Public Ownership

一般大众所有权

The general public-- including retail investors -- own 29% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

尽管考虑不同拥有公司的团体是值得的,但有些因素更为重要。例如,我们已经为中国医药系统控股公司确定了2个警示信号,您应该注意到这些信号。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For instance, we've identified 2 warning signs for China Medical System Holdings that you should be aware of.

none

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最终,决定该业务所有者将获得多大利益的是未来而非过去。因此,我们认为最好查看此免费报告,以了解分析师是否预测更光明的未来。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发